IRS1 promotes thyroid cancer metastasis through EMT and PI3K/AKT pathways.
Fang YuDongdong HuangYeye KuangJian DongQingmei HanJie ZhouXiaodong TengPublished in: Clinical endocrinology (2024)
IRS1 overexpression contributes to the aggressiveness of thyroid cancer and is expected to be a stratified marker and a potential therapeutic target for thyroid cancer.